Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases

Volume: 174, Issue: 18, Pages: 3032 - 3044
Published: Aug 11, 2017
Abstract
Background and Purpose Morin is a natural occurring flavonoid in many dietary plants and has a wide range of beneficial effects on metabolism; however, the mechanism underlying its action remains elusive. Experimental Approach A reporter assay and the time‐resolved FRET assay were used to identify morin as a dual antagonist of liver X receptor (LXR)‐α and ‐β. Morin (100 mg . 100 g ‐1 diet) was administered to high‐fat diet‐induced obese or LXRβ...
Paper Details
Title
Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases
Published Date
Aug 11, 2017
Volume
174
Issue
18
Pages
3032 - 3044
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.